Automated description from the Alliance of Genome Resources (Release 7.1.0)
Predicted to enable chromatin binding activity and histone binding activity. Predicted to be involved in negative regulation of DNA-templated transcription and negative regulation of gene expression. Predicted to be located in aggresome; cytosol; and nuclear speck. Predicted to be active in nucleus. Is expressed in several structures, including extraembryonic component; liver; lung; placenta; and spleen. Orthologous to human SFMBT2 (Scm like with four mbt domains 2).